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A B S T R A C T
Sporadic cerebral small vessel disease is an important cause of vascular dementia, a syndrome of cognitive
impairment together with vascular brain damage. At post-mortem pure vascular dementia is rare, with evidence
of co-existing Alzheimer's disease pathology in 95% of cases. This work used MRI to characterize structural
abnormalities during the preclinical phase of vascular dementia in symptomatic small vessel disease.
121 subjects were recruited into the St George's Cognition and Neuroimaging in Stroke study and followed up
longitudinally for ﬁve years. Over this period 22 individuals converted to dementia. Using voxel-based mor-
phometry, we found structural abnormalities present at baseline in those with preclinical dementia, with re-
duced grey matter density in the left striatum and hippocampus, and more white matter hyperintensities in the
frontal white-matter. The lacunar data revealed that some of these abnormalities may be due to lesions within
the striatum and centrum semiovale.
Using support vector machines, future dementia could be best predicted using hippocampal and striatal
Jacobian determinant data, achieving a balanced classiﬁcation accuracy of 73%. Using cluster ward linkage we
identiﬁed four anatomical subtypes. Successful predictions were restricted to groups with lower levels of vas-
cular damage. The subgroup that could not be predicted were younger, further from conversion, had the highest
levels of vascular damage, with milder cognitive impairment at baseline but more rapid deterioration in pro-
cessing speed and executive function, consistent with a primary vascular dementia. In contrast, the remaining
groups had decreasing levels of vascular damage and increasing memory impairment consistent with progres-
sively more Alzheimer's-like pathology. Voxel-wise rates of hippocampal atrophy supported these distinctions,
with the vascular group closely resembling the non-dementing cohort, whereas the Alzheimer's like group de-
monstrated global hippocampal atrophy.
This work reveals distinct anatomical endophenotypes in preclinical vascular dementia, forming a spectrum
between vascular and Alzheimer's like pathology. The latter group can be identiﬁed using baseline MRI, with
73% converting within 5 years. It was not possible to predict the vascular dominant dementia subgroup, however
19% of negative predictions with high levels of vascular disease would ultimately develop dementia. It may be
that techniques more sensitive to white matter damage, such as diﬀusion weighted imaging, may prove more
useful for this vascular dominant subgroup in the future.
This work provides a way to accurately stratify patients using a baseline MRI scan, and has utility in future
clinical trials designed to slow or prevent the onset of dementia in these high-risk cohorts.
1. Introduction
It is generally accepted that future treatments for dementia should
aim to start prior to symptom onset, when extensive pathology will
already be present and diﬃcult to reverse (Langbaum et al., 2013).
Therefore accurately identifying individuals during the preclinical
phase of their illness is paramount to developing eﬀective therapies.
Vascular cognitive impairment is deﬁned as a syndrome in which at
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least one cognitive domain is impaired, together with evidence of
vascular damage (Thal et al., 2012), and becomes vascular dementia
once a second cognitive domain becomes aﬀected (Gold et al., 1997).
This clinically heterogeneous entity is the second most common cause
of dementia after Alzheimer's disease (Jellinger and Attems, 2010), and
can manifest due to a broad range of sporadic and familial conditions
where the net result is vascular damage to the brain. The most common
cause is cerebral small vessel disease (SVD), a highly prevalent, age-
related condition aﬀecting the small vessels of the brain (De Leeuw
et al., 2001; Pantoni, 2010) that is associated with characteristic
changes on magnetic resonance imaging (MRI) including white matter
hyperintensities (WMH), lacunar infarcts, cerebral microbleeds, and
brain atrophy (Gouw et al., 2011).
This work examines, in a cohort followed for 5 years, the structural
correlates of preclinical vascular dementia using MRI to predict the
development of future dementia in a cohort of individuals with sporadic
“symptomatic small vessel disease”, deﬁned as both clinical and radi-
ological evidence of a lacunar syndrome together with conﬂuent WMH
(modiﬁed Fazekas grade≥ 2), but without evidence of large cortical
infarcts, cerebral amyloid angiopathy or other cause of white matter
disease.
1.1. Dementia in cerebral small vessel disease – pathology
The most common pattern of pathology observed in vascular de-
mentia is a subcortical vascular encephalopathy. This is used to de-
scribe a severe form of SVD due to arteriolosclerosis and lipohyalinosis
(Ferrer, 2010; Thal et al., 2012), appearing as conﬂuent leukoaraiosis
on brain imaging with sparing of the cortico-cortical u-ﬁbers (Jellinger
and Attems, 2010). It is thought that the white matter damage in leu-
koaraiosis leads to dementia by way of a progressive disconnection
syndrome due to damage of the cortical-subcortical and cortical-cortical
connections (Lawrence et al., 2013). In addition single strategic infarcts
may also cause or contribute to dementia when structures normally
involved in mediating cognitive processes are damaged, for example the
thalamus (particularly the paramedian or medio-dorsal thalamic nuclei)
and hippocampi (Ferrer, 2010; Benjamin et al., 2014). However it
should be noted that pure vascular dementia is rare at post-mortem,
performed predominantly in elderly individuals, with histological evi-
dence of co-existing Alzheimer's disease pathology present in 90–95%
of cases (Jellinger and Attems, 2010; Thal et al., 2012).
1.2. Dementia in cerebral small vessel disease – clinical
The characteristic cognitive pattern associated the subcortical
white-matter disease caused by SVD is that of prominent executive
function and processing speed dysfunction, with relative preservation
of episodic memory (Lawrence et al., 2013). In contrast, Alzheimer's
disease and the mixed dementia subtypes are typiﬁed by more marked
memory involvement (Reed et al., 2007).
1.3. Dementia in cerebral small vessel disease – MRI correlates
Whilst cognitive impairment in SVD has been shown to associate
with a number of diﬀerent MRI features including lacunar infarcts,
WMH, and less consistently microbleeds (Patel and Markus, 2011;
Benjamin et al., 2014), the imaging correlates of vascular dementia are
less well deﬁned. The most consistent ﬁnding is increased deep white
matter hyperintensities (Smith et al., 2016; Altamura et al., 2016), as-
sociated with measures of reduced integrity of the white matter struc-
tural network (Tuladhar et al., 2016), which in combination have been
found to be predictive of progression to future dementia. Whilst these
previous MRI studies have not distinguished between vascular de-
mentia subtypes, PET imaging using Pittsburgh compound B (PiB) to
detect the β-amyloid protein has allowed the spectrum between the
pure vascular, mixed and pure Alzheimer's dementias to be better
characterized (Lee et al., 2011). These studies have found that in-
dividuals with pure vascular dementia are younger with substantially
more lacunar infarcts (Lee et al., 2011; Kim et al., 2014) compared to
those with evidence of co-existing β-amyloid pathology.
1.4. Hypotheses
Here we test the hypothesis that, within a cohort of individuals with
symptomatic small vessel disease, there are particular localized struc-
tural abnormalities in those destined to convert to dementia within ﬁve
years (“preclinical vascular dementia”) that can be identiﬁed from the
baseline structural imaging (T1-weighted and FLAIR MRI).
Furthermore, simple machine learning techniques (i.e. support vector
machines) can be used to predict future dementia from the baseline MRI
imaging. We also test the hypothesis that vascular dementia is asso-
ciated with diﬀerences in the voxel-wise rate of cortical atrophy or
WMH expansion. Finally, due to the known heterogeneous nature of
vascular dementia, we aimed to use the structural imaging to deﬁne
whether distinct anatomical endophenotypes exist within the pre-
clinical cohort, and if so, were there any diﬀerences in the clinical
manifestation or disease progression between these groups.
2. Methods
2.1. Subjects
Supplementary Fig. 1 summarizes the baseline and longitudinal data
used, conversion to dementia and reasons for dropout. This work pri-
marily focused on stratifying preclinical dementia based on the initial
baseline assessment, and therefore included all individuals irrespective
of their long-term outcome.
2.2. Subjects - baseline
121 subjects (78 male, mean age male= 67.96 ± 10 years, fe-
male= 73.74 ± 8.12 years) with symptomatic SVD were recruited as
part of the prospective St George's Cognition and Neuroimaging in
Stroke (SCANS) study (Lawrence et al., 2013). Recruitment was from
acute stroke units or outpatient stroke clinics in three hospitals covering
a contiguous catchment area in South London (St George's, King's
College and St Thomas' Hospitals). Inclusion criteria comprised a clin-
ical lacunar syndrome (Bamford et al., 1987) with an anatomically
corresponding lacunar infarct in addition conﬂuent WMH on MRI
(modiﬁed Fazekas grade≥2) (Fazekas et al., 1987; Hassan et al., 2003)
on MRI. Exclusion criteria were: any cause of stroke mechanism other
than SVD, other major central nervous system disorders, major psy-
chiatric disorders, any other cause of white matter disease, contra-
indications to MRI, or non-ﬂuent in English. All subjects provided
written consent, and the study was approved by the local ethics com-
mittee. The study is registered with UK Clinical Research Network
(http://public.ukcrn.org.uk/, study ID:4577). The T1-weigthed MRI for
two of these individuals was corrupted by artifact (see Lambert et al.,
2015) that resulted in very inaccurate tissue segmentations and there-
fore were excluded from this work. The remaining 119 individuals were
used for all baseline analysis.
2.3. Subjects – longitudinal
Subjects were invited for cognitive testing and clinical assessment
annually for ﬁve years. During the ﬁrst three years they also underwent
annual MRI scanning. Recruitment began in December 2007 and ended
in August 2010. MRI scanning began in January 2008 and was com-
pleted in October 2013. If a participant was diagnosed with dementia at
any point over the ﬁve years, they were allocated to the preclinical
vascular dementia (PreVaD) baseline cohort.
In the MRI longitudinal rate analysis, follow-up data up to year
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three was used (i.e. the complete longitudinal MRI dataset), providing a
maximum of four datasets per individual. Of these, 99 subjects returned
at one or more time-points: 98 at year one, 77 at year two and 71 at
year three. One subject attended the baseline and missed the year one
follow up, but attended all subsequent sessions. Four subjects missed
the year two follow up, but subsequently attended at year three.
Additionally, over the period reported there were three new clinical
strokes, two lacunar and one cortical haemorrhage. Intracerebral hae-
morrhage was a pre-deﬁned end-point and the patient was withdrawn
from the study. The two lacunar stroke cases were allowed to remain in
the study, as stated in the protocol, although one subsequently with-
drew due to disability. This is summarized in Supplementary Fig. 1. All
available longitudinal data (n=99) was used in the rate analysis, of
whom 17 ultimately developed dementia.
2.4. Conversion to dementia - deﬁnition
Information on conversion to dementia was available for all pa-
tients. Dementia was diagnosed using the “Diagnostic and Statistical
Manual of Mental Disorders V" (DSM–V) (American Psychiatric
Association, 2013) deﬁnition of “major neurocognitive disorder”, and was
present if individuals met one of the following criteria:
1. A diagnosis of dementia made in a memory clinic or equivalent
clinical service.
2. After review of medical records and cognitive assessments by a
neurologist and clinical neuropsychologist who were both blind to
all MRI and risk factor information and who both agreed that the
clinical picture met DSM-V criteria for dementia.
3. An MMSE score consistently< 24, indicative of cognitive impair-
ment (Tombaugh and McIntyre, 1992) and reduced capabilities in
daily living as measured by a score≤ 7 on the iADL (Barberger-
Gateau et al., 1992).
In all cases the presence or absence of dementia was determined
before comparison of the cognitive and MRI data. Date of dementia
onset was deﬁned as the date of diagnoses. If no exact date was known
and dementia conversion was based on review of patient data or cog-
nitive performance, the mid-point date between the patient's visit at
which the diagnosis was established and the previous visit was used. If a
participant was diagnosed with dementia at any point over the ﬁve
years following recruitment, they were allocated to the preclinical
vascular dementia (PreVaD) baseline cohort. No participant met the
clinical DSM V criteria for vascular dementia at the time of recruitment,
though one individual met research criteria at the baseline assessment.
We elected to include this individual; on the basis we were testing what
could be inferred from baseline imaging data alone.
2.5. Image acquisition
All subject MR images were acquired using the Signa HDxt 1.5 T
Magnetic Resonance Scanner (General Electric, Milwaukee, WI, USA) at
St George's, University of London. The maximum gradient amplitude
was 33mTm−1 and a proprietary 8-channel head coil was used. All
subjects were placed in the head coil and an alignment marker was used
at the nasal bridge. Velcro straps and foam pads were used where
possible to minimize head movement. Whole brain T1-weighted and
FLAIR images were acquired for each subject using the following pro-
tocol: (1) Fluid Attenuated Inversion Recovery (FLAIR) sequence - TR/
TE/TI= 9000/130/2200 ms, ﬁeld-of-view (FOV)=240×240mm2,
matrix= 256×192, 28 axial slices of 5mm thickness reconstructing to
a ﬁnal image resolution of 0.47× 0.47× 5mm3. (2) Spoiled gradient
echo recalled T1-weighted (SPGR) 3D coronal sequence - TR/
TE=11.5/5ms, FOV=240×240mm2, matrix= 256×192, ﬂip
angle= 18o, 176 coronal slices of 1.1 mm thickness reconstructing to a
ﬁnal image isotropic resolution of 1.1 mm.
2.6. Pre-processing
The raw DICOMS were imported using the SPM8 software package
(http://www.ﬁl.ion.ucl.ac.uk/spm/software/spm8/), and each image
checked to ensure a common orientation. Initially the T1-weighted and
FLAIR images were co-registered together using an aﬃne transforma-
tion in SPM for each individual, before rigid transformation to the same
orientation as the MNI template and resliced to 1mm isotropic re-
solution using 4th degree b-spline interpolation.
2.7. Segmentation
The segmentation steps adapted and optimized to our study popu-
lation have been described in detail in Lambert et al., 2015 and Lambert
et al., 2016a, but are summarized below and a full description provided
in the supplementary material (Supplementary Material). The adapted
segmentation pipeline consisted of four steps. First, a group average
template was created and non-linear warps used to transform the T1-
weighted and FLAIR images to this space. Second, the warped T1-
weighted and FLAIR images were used to create population speciﬁc
tissue probability maps (TPMs). Third, the newly created TPMs were
used to re-segment the native images creating grey matter (GM), white
matter (WM), cerebrospinal ﬂuid (CSF) and WMH tissue classes. These
were then combined with the manually deﬁned lacune ROIs (detailed
below), resulting in ﬁve tissue classes per individual. Finally, a tissue
repair step was performed to generate repaired GM, WM and CSF maps
for each individual dataset. The VBCT toolbox (Hutton et al., 2008) in
SPM8 was used to calculate cortical thickness (CT) using the ﬁnal re-
paired segmentations with a sampling resolution of 0.5mm, CSF
smoothness 3mm, CSF thinness 0.65 and number of dilations was set to
one.
2.8. Lacune delineation
Areas of lacunar infarction were manually identiﬁed on native space
T1-weighted images using published criteria (Benjamin et al., 2014;
Lambert et al., 2015). This was aided by overlaying CSF segmentations
on corresponding FLAIR images to identify regions of misclassiﬁcation.
Regions were segmented using a space-ﬁlling algorithm in ITK-SNAP
(Yushkevich et al., 2006), using voxel intensity thresholds (set to be-
tween 350 and 500) with 500 iterations. These results were visually
checked and manually reﬁned where necessary. This step was per-
formed independently by two raters (CL and PB), and inter- and intra-
rater reliability checked using 10 randomly selected scans across all
time points, duplicated to provide a total set of 20 scans per rater, each
set randomly re-ordered for each rater to avoid any sequence bias. Both
raters were blinded with respect to subject and time-point of each scan.
The inter-rater reliability metrics were: Standard error of
mean=3mm3, mean variability= 7.93% (standard devia-
tion= 4.89%), Pearson's intra-class correlation coeﬃcient= 0.99. The
corresponding intra-rater reliability metrics were: Standard error of
mean=2mm3, mean variability= 4.32% (standard devia-
tion= 4.19%), Pearson's intraclass correlation coeﬃcient= 0.99.
There were no signiﬁcant diﬀerences between the volumes measured by
the two raters.
2.9. Cerebral microbleeds
CMB were deﬁned as homogeneous round focal areas< 10mm in
diameter of low signal intensity on T2*-weighted GRE images. Only
CMB meeting the Brain Observer Microbleed Rating Scale (BOMBS)
(Cordonnier et al., 2009) criteria for “certain” CMB were analyzed.
Presence and number of CMB at baseline were identiﬁed by a single
consultant neuroradiologist. CMB number reliability metrics were
checked using a subset of 10 randomly selected subjects. The intra-class
correlation coeﬃcient was 0.99.
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2.10. Baseline warping pipeline
All baseline repaired segmentation maps were visually checked for
quality in native space and then warped to a ﬁnal 1mm isotropic group
average template using a diﬀeomorphic-warping algorithm (the Shoot
toolbox in SPM12 (Ashburner and Friston, 2011)) to generate an opti-
mized group average image for further analysis. Using the same ap-
proach, the WMH maps were also warped to their own group average
space.
2.11. Longitudinal warping pipeline
To calculate longitudinal volumetric changes in small vessel disease
and to enable statistical analysis regardless of the number of time-
points, we developed a two stage-warping pipeline by adapting the
available SPM framework (described in detail in Lambert et al., 2016a,
2016b), also provided in the Supplementary material) that ﬁrst warped
each subject to an individual average template that represents the
average mid-point brain. This step provides a voxel wise trajectory,
based upon the non-linear deformations to the average individual brain,
for each time-point. These are expressed as divergence maps (for each
time-point) in SPM as detailed below. To create a “rate map” we per-
formed a voxel-wise linear ﬁt between the divergence maps, using the
time between scans as the basis (as per Ashburner and Ridgway, 2012).
These individual rate maps show the relative speed of tissue expansion
or contraction for every voxel in the brain per year and were used for
analysis. For each subject, the following images from individual
average space were warped to the group average template: Grey matter
template, white matter template, WMH template, lesion rate maps and
repaired rate maps. Each of the warped tissue classes was multiplied by
the warped rate maps.
2.12. Whole brain MRI parameters
For each scan, the unrepaired segmentations were used to calculate
tissue volumes. The lacunar infarcts, total cerebral volume (TCV, de-
ﬁned as the sum of grey matter, white matter and WMH at a tissue
probability threshold≥0.2) and total intracranial volume (TIV, deﬁned
as TCV plus the CSF volume at a set tissue probability threshold ≥0.2,
constrained by the ﬁnal brain inclusion mask) were calculated in mm3.
The WMH volumes were calculated by binarising the segmentations at a
manually determined threshold for each individual as detailed in the
segmentation methodology (Supplementary material). We also calcu-
lated the ratio of WMH to the TCV (SVDp). This measure combines
atrophy and WMH as a measure of severity, and prevents erroneous
regression of WMH that may occur with zero WMH growth occurring
against a background of continuing brain atrophy. For each long-
itudinal dataset, the annualized rate of change was calculated from all
available time points (e.g. time in years from baseline) using a least
squares linear ﬁt in MATLAB 2013a. All MRI parameters were sum-
marized according dementia convertors and non-convertors.
2.13. Cognitive assessment
A battery of well-established, standardised tasks sensitive to the
cognitive impairments seen in SVD was carried out annually. Full de-
tails have been published previously (Lawrence et al., 2013), and are
summarized in Supplementary Table 1. In brief, premorbid intelligence
was assessed using the National Adult Reading Test-restandardised
(NART) (Nelson and Willison, 1991) and the MMSE was used as a de-
mentia screening tool. All other tasks were age-scaled using published
normative data, converted to z-scores and grouped into broad cognitive
domains. Averaging across component scores within each cognitive
domain created four cognitive index scores (Supplementary Table 1):
Executive function (EF), processing speed (PS), working memory (WM)
and long-term (episodic) memory (LTM). An overall global functioning
score based on all administered tests was also produced. The cognitive
index scores were based on the following tasks: Executive function –
Trail making test part B (Reitan, 1958), phonemic ﬂuency (Delis et al.,
2001), and the modiﬁed Wisconsin card-sorting test (Nagahama et al.,
2003). Processing speed – Digit symbol substitution (Wechsler, 1997),
the grooved pegboard task (Klove, 1963; Mitrushina et al., 2005), and
the BMIPB speed of information processing speed test (Coughlan et al.,
2007). Working Memory – Digit span (Wechsler, 1997). Long Term
Memory – Logical memory and visual reproduction (Wechsler, 1997).
2.14. Statistical data analysis
All analysis was performed in MATLAB 2013a unless speciﬁed, and
the data was grouped either according to time-point or outcome as
speciﬁed. The normally distributed data was explored initially using an
ANOVA, and if signiﬁcant a two-sample t-test was used to examine
diﬀerences between groups. Non-parametric data was tested using a
Kruskal-Wallis test. Results signiﬁcant at P < 0.05 were reported.
2.15. Lacunar infarct analysis
All lacunar infarct maps were warped to the group average space
and used to create overlap maps for the two groups. To assess the dif-
ferences between the two groups, a third map was created that iden-
tiﬁed regions where there were more infarcts present in the dementia
group compared to the normal group. To assess the distribution of the
lacunar infarcts, the following atlases were warped to the population
average space using FNIRT in FSL: The Harvard-Oxford Subcortical
Atlas (21 subcortical labels, available in FSL), the ICBM-DTI-81 white-
matter labels atlas (48 white matter labels, available in FSL), tracto-
graphy segmented thalamic nuclei (9 nuclei, taken from Lambert et al.,
2016a, 2016b). For each region of interest, the percentage of in-
dividuals where a lacunar infarct was present (and more than 10mm3
(Benjamin et al., 2014)) were calculated. These results are summarized
in Supplementary Table 1.
2.16. Baseline statistical image analysis
All statistical image analysis was performed in SPM12. The baseline
segmentations for GM, WM and WMH were warped to their group
average space, modulated by multiplying by the Jacobian determinant,
and smoothed using a 6mm FWHM Gaussian kernel. The warped CT
maps were used to generate FWHM 6mm smoothed warped weighted
average (WWA) images produced as described by Draganski et al., 2011
(Hutton et al., 2009; Draganski et al., 2011). These were all analyzed
using a two-sample t-test in SPM to test for structural diﬀerences be-
tween those destined to convert to dementia versus those not. Age,
gender, lacune infarct volume, TIV and NART were included as cov-
ariates. Regions that survived FWE multiple comparison correction at
P < 0.05 were deemed signiﬁcant. To better explore the FWE sig-
niﬁcant regions, they are displayed at both P < 0.001 uncorrected and
P < 0.05 FWE corrected for multiple comparisons in the ﬁgures and
appropriate legends provided.
2.17. Longitudinal analysis
2.17.1. Longitudinal MRI and cognitive parameters
Linear mixed eﬀect (LME) models to estimate annualized change
rates in cognitive indices based on all available time-points using
MLwiN 2.1 (Centre for Multilevel Modelling, University of Bristol
(Rasbash et al., 2009). Random eﬀect slopes for each patient as esti-
mated by the LME models were extracted and used for further analyses.
This data was used to assess the baseline anatomical clustering de-
scribed below.
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2.17.2. Longitudinal statistical image analysis
The objective was to test for voxel wise diﬀerences in the rates of
GM atrophy or WMH growth between the convertors and non-con-
vertors. WWA rate maps were generated for the GM and WMH as
previously described, and analyzed using a two-sample t-test in SPM12
to test for structural diﬀerences between those destined to convert to
dementia versus those not as described above.
2.18. Prediction analysis
To further investigate the relationship between the MRI changes
and dementia, we attempted to predict conversion from the baseline
structural imaging data using a kernel based support vector machine
(SVM) from the PRoNTo v2.0 toolbox (http://www.mlnl.cs.ucl.ac.uk/
pronto/) (Schrouﬀ et al., 2013). The same settings were used for all
analysis: Binary SVM, age, sex, TIV and NART included as potential
confounders, default hyperparameters, leave-one-out cross validation,
mean centre features using training data, permutation test using 10,000
permutations. The following structural maps were separately tested:
Jacobian determinant image, warped lacunar map, warped modulated
WMH, smoothed warped weighted-average CT maps and the smoothed
warped modulated GM and WM. To clarify the subcortical contribution,
SVM predictions were also tested using masked Jacobian determinant
images. The bilateral striatum (putamen and caudate), hippocampi and
thalamic masks from the AAL atlas (provided in the PRoNTo toolbox)
were used. If signiﬁcant at P < .05, prediction quality was quantita-
tively assessed across a range of parameters including total classiﬁca-
tion accuracy, balanced classiﬁcation accuracy, sensitivity, speciﬁcity,
positive predictive value, negative predictive value and area under the
receiver operator curve.
2.19. Cluster analysis
The Jacobian determinant images that had been generated from
warps using the GM, WM, WMH, LI and CSF were used to characterize
the structural similarities between the dementia cohort using cluster
ward linkage. Initially, these were masked using a skull-striped brain
mask and all voxels within this were extracted and used to generate a
22×N matrix of Jacobian determinant values (where N= total brain
volume). From this, a 22× 22 correlation matrix was created and used
to calculate the Euclidean distance between each individual. Ward-
linkage was then used to generate a dendrogram, to visualise these si-
milarities, and the prediction accuracies were superimposed. Four
groups were selected based on visual inspection of the dendrogram and
explored further. Due to the small numbers within each group formal
between-group statistics were not possible, however to better under-
stand nature of the sub-groups the corresponding demographic, MRI
and cognitive parameters were extracted and summarized. To better
understand the anatomical basis of the group diﬀerences, the average
rate of hippocampal atrophy was calculated from the rate maps.
2.20. Survival analysis
Kaplan-Meier survival curves between the positive and negative
predictions and time to dementia onset were generated using MATLAB.
These were also further stratiﬁed by examining the impact of vascular
burden (deﬁned as a SVDp of more or< 4%) on the SVM prediction
survival curves. Diﬀerences between the survival curves were tested
using the log-rank test (using “logrank” from the MATLAB ﬁle ex-
change: http://www.mathworks.com/matlabcentral/ﬁleexchange/
20388-logrank/content/logrank.m).
3. Results
3.1. Baseline demographics
Out of the baseline cohort (n= 119), 22 individuals (18.5%) de-
veloped dementia during follow-up with a mean time to conversion of
3.02 ± 1.50 years; we now refer to these as the preclinical vascular
dementia cohort (preVaD). The demographics, cognitive and MRI
parameters for these groups are summarized in Table 1. The only sig-
niﬁcant diﬀerence at baseline between those who did and did not
convert to dementia at baseline after Bonferroni correction was the
MMSE (Median (range): Normal= 29 (22−30), PreVaD=26
(16–30)).
3.2. Lacunar analysis
Diﬀerences in overlapping regions of lacune infarcts are shown in
Fig. 1, and summarized in Supplementary Table 2. Whilst there were
more lacunes present in the preVaD cohort (Table 1), this was not
signiﬁcant. When lacunes were present, they were more frequently lo-
cated in the preVaD group (diﬀerence in the percentage of individuals
with a lacune infarct greater or equal to 9%) particularly within in the
striatum, corona radiata and internal capsule. Additionally, the preVaD
Table 1
Baseline demographics and parameters for cohort. All values are mean (stan-
dard deviation) unless labelled otherwise.
Cohort
BASELINE PARAMETERS Future non-
dementia
Future
dementia
Drmographics N 97 22
Average age (years) 69.49 (9.54) 73.20 (9.38)
Male (%) 60.82 77.27
Female (%) 39.18 22.73
Rankin 1.09 (0.99) 1.59 (1.47)
Diabetes (%) 81.44 86.36
Non-Smoker (%) 47.42 38.1
Ex-Smoker (%) 34.02 42.85
Current Smoker (%) 18.56 19.05
Treated Hypertension (%) 92.78 90.91
Treated
Hypercholesterolaemia (%)
85.57 86.36
Average time to dementia
onset (years)
– 3.02 (1.49)
Average age of dementia onset
(years)
– 76.23
MRI Parameters Mean grey matter (mm3) 681,213
(76616)
670,374
(68616)
Mean white matter (mm3) 333,930
(56698)
320,761
(56010)
Mean total cerebral volume
(mm3)
1,052,347
(114243)
1,036,447
(109535)
Mean lacunar volume (mm3) 468 (671) 646 (661)
Mean white matter
hyperintesities volume (mm3)
37,204
(36937)
45,312
(30469)
SVDp: Percentage ratio of
WMH to GM volumes (%)
3.48 (3.01) 4.34 (2.99)
Cognitive MMSE (Median and range)⁎⁎⁎ 29 (22–30) 26 (16–30)
NART⁎ 100.03
(15.35)
93 (14.96)
Executive function⁎⁎ −0.78 (1.07) −1.35 (1.02)
Processing speed −0.83 (0.85) −1.21 (0.95)
Global functioning⁎ −0.49 (0.83) −0.90 (0.82)
Working memory −0.16 (0.94) −0.30 (0.93)
Long-term memory 0.01 (0.98) −0.44 (0.91)
Bonferroni corrected P < 0.003.
⁎ P < 0.05.
⁎⁎ P < 0.01.
⁎⁎⁎ P < .001.
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cohort demonstrated greater asymmetry, with more lacunar infarcts
located within the left-hemisphere. Whilst the number of thalamic la-
cunes were reasonably equal (32% preVaD, 30% normal), analysis of
the sub-nuclei revealed more located (diﬀerence greater than or equal
to 9%) within the ventro-anterior, mediodorsal, ventro-posterior and
pulvinar in the preVaD group. Together, these ﬁndings indicate that a
proportion of those with preclinical dementia already have strategic
lacunes within structures associated with memory and language.
3.3. Voxel based morphometry
Regions of signiﬁcantly reduced grey matter density in the preVaD
group are shown in Fig. 2. It demonstrates maked reduction in grey
matter density within the left striatum, which is likely due to the dis-
tribution of lacunes. To a much lesser extent, reduced grey matter
density is observed in the left anterior hippocampus and posterior
portion of the right putamen.
Regions of signiﬁcantly increased WMH were also found in the
Fig. 1. Distribution of lacunes between the preclinical dementia and non-dementing patient cohorts.
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preVaD group, as shown in Fig. 2. It demonstrates more WMH within
the frontal radiations. No signiﬁcant WM changes were found
(P < 0.05).
3.4. Cortical thickness
No signiﬁcant regions were found (FWE P < 0.05).
3.5. Longitudinal rate analysis
No signiﬁcant regions were found in the voxel wise analysis of the
GM, WM or WMH rate maps (FWE P < 0.05).
3.6. Preclinical vascular dementia - SVM prediction
To better characterize the VBM analysis, we set out to test if future
Fig. 2. Voxel-based morphometry regions of decrease GM density and increased white-matter hyperintensities between the preclinical dementia and normal patient
cohorts. *P < 0.001 uncorrected, **P < 0.05 FWE corrected.
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dementia could be predicted from voxel-wise, baseline MRI parameters
using support vector machines. These results are summarized in
Table 2. Overall, the most accurate predictions (judged by the balanced
accuracy) were achieved using grey matter volumetric data. These ap-
pear to be particularly driven by the subcortical structures, with the
striatum, hippocampus and to a lesser extent the thalamus, each able to
independently predict future dementia (P < 0.01). The best predic-
tions were achieved using combined striatal-hippocampal masks, pro-
viding a total prediction accuracy of 84.87%, balanced prediction ac-
curacy of 73.17% (P < 0.01), class sensitivity 55% (P < 0.01),
speciﬁcity 92% (P < 0.05) and an area under the receiver operator
curve (c statistic) of 0.84.
3.7. Preclinical dementia – anatomical subgroups
Four subgroups were identiﬁed (Fig. 3, Table 3) on the basis of the
dendrogram. Subgroups diﬀered in the extent to which the SVM was
able to correctly predict dementia. Examination of the negative pre-
diction group revealed that the missed preclinical dementias all had
signiﬁcant vascular damage. By plotting the sensitivity and speciﬁcity
curves over a range of SVDp, the optimal threshold for discriminating
the negative prediction preclinical dementia group was SVDp=4%
(sensitivity= 64%, speciﬁcity= 68%), and therefore we used that as
the deﬁnition for “high” and “low” vascular burden (also shown on
Fig. 3).
In terms of the identiﬁed anatomical groups: Group 1 (n= 5) was
associated with the highest burden of vascular disease, more cortical
atrophy, a relatively normal baseline cognitive proﬁle compared to the
population average but more rapid deterioration in EF and PS, faster
increases in SVDp and new lacunes, and a younger age of dementia
onset. This pattern is consistent with primary vascular dementia (Kim
et al., 2014), and could not be predicted through the best performing
SVM analysis. Group 4 (n=10) had the lowest level of vascular da-
mage and whole brain atrophy, but poor baseline cognitive proﬁle in all
domains, notably working and long-term memory, and high levels of
annual deterioration in the cognitive parameters but the lowest in the
MRI SVDp parameters. This pattern is more Alzheimer's like, and 70%
of cases could be predicted at baseline. Group 2 (n=2) and group 3
(n=5), which were more similar on the dendrogram, fell between
these two extremes. Despite small numbers in each group, we aimed to
further validate this observation by calculating the voxel-wise atrophy
for the hippocampi (Fig. 4). This demonstrates that group 1 has a si-
milar pattern of anterior hippocampal atrophy as the non-dementing
cohort, where as group 4 is characterized by a much more global pat-
tern. These observations are in keeping with previously described pat-
terns of hippocampal atrophy in ageing and Alzheimer's (Frisoni et al.,
2008).
3.8. Preclinical dementia – anatomical subgroups
The Kaplan-Meier survival curves are shown in Fig. 5. There is a
signiﬁcant diﬀerence between those predicted at baseline to develop
dementia using SVM versus those not. The median survival time for the
positive predictions is 3.5y (P < 0.005), corresponding to a 93%
probability of survival in the negative prediction group. Due to the
observed sub-group eﬀect associated with high levels of vascular dis-
ease causing false negatives, the groups were stratiﬁed by vascular
burden. Taking this into account (Fig. 4B), in those with a positive SVM
prediction at baseline 73% with a low vascular burden and 60% with a
high vascular burden will convert to dementia within 5y, compared to
the negative predictions where 6% of the low vascular burden and 19%
high vascular burden will develop dementia over the same timeframe.
4. Discussion
This study has demonstrated that within a cohort of patients with
symptomatic cerebral small vessel disease there are anatomical ab-
normalities present in MRI during the preclinical phase of vascular
dementia that can be used to accurately predict future dementia.
Furthermore, we have demonstrated the existence of distinct patholo-
gical subgroups, based on anatomical diﬀerences detected using base-
line MRI appearances, within those individuals who developed de-
mentia during the ﬁve-year follow-up. These subgroups are consistent
with a spectrum from a primary vascular dementia, with an extremely
high burden of vascular disease, more rapid deterioration in EF and PS,
and a younger age of dementia onset, that could not be predicted
through SVM analysis, through to an older group with low level of
vascular damage and whole brain atrophy, poor baseline cognitive
proﬁle in all domains, notably working and long term memory, with
high levels of annual deterioration, reﬂecting a more Alzheimer's like
pattern that could be predicted in 70% of cases. Two groups fell be-
tween these extremes and appear to represent a spectrum of mixed
Table 2
SVM predictions using baseline MRI data.
Total
accuracy %
Balanced
accuracy %
Balanced
accuracy P
value
Class accuracy % Class accuracy P value Class predictive value % ROC
Sensitivity Speciﬁcity Sensitivity Speciﬁcity Positive
predictive value
Negative
predictive value
Jacobian 83.19 63.33 0.01 31.82 94.85 0.01 0.82 58.33 85.98 0.79
GM 84.87 74.36 0.01 31.82 96.91 0.01 0.07 70 86.24 0.79
WM 79.83 52.48 0.1 9.09 95.88 0.24 0.12 33.33 82.3 0.62
WMH 79.83 54.24 0.01 13.64 94.85 0.01 0.95 37.5 82.88 0.65
Lacunar 84.03 56.82 0.01 13.64 100 0.02 0.06 100 83.62 0.64
Cortical Thickness 79.83 57.76 0.01 22.73 92.78 0.02 0.52 41.67 84.11 0.71
Putamen 82.35 68.09 0.01 45.45 90.72 0.01 0.04 52.63 88 0.78
Caudate 78.99 60.75 0.01 31.82 89.69 0.04 0.05 41.18 85.29 0.73
Striatum (Putamen +
Caudate)
80.67 65.3 0.01 40.91 89.69 0.01 0.15 47.37 87 0.77
Hippocampus 83.19 65.09 0.01 36.36 93.81 0.02 0.01 57.14 86.87 0.8
Thalamus 80.67 61.79 0.01 31.82 91.75 0.01 0.01 46.67 85.58 0.72
Putamen + Hippocampus 84.87 69.93 0.01 45.45 93.81 0.01 0.01 62.5 88.35 0.84
Striatum + Hippocampus 84.87 73.17 0.01 54.55 91.75 0.01 0.05 60 89.9 0.84
Putamen + Hippocampus
+ Thalamus
83.19 70.36 0.01 50 90.72 0.01 0.15 55 88.89 0.81
Striatum + Hippocampus
+ Thalamus
82.35 66.33 0.01 40.91 91.75 0.01 0.15 52.94 87.25 0.81
The masked analysis used subcortical ROIs and the Jacobian determinant data. The best prediction (judged by balanced accuracy) was achieved using the combined
striatum-hippocampus mask, which was signiﬁcant at P < 0.01 using permutation testing (10,000 permutations)
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Fig. 3. Anatomical subgroups in the preclinical dementia cohort. A) Dendrogram generated using ward-linkage on the unrepaired Jacobian determinant images.
Dashed line shows the cut-oﬀ used to identify the four subgroups. The successful support vector machine predictions are shown (X), and the level of vascular damage
indicated (dark grey - SVDp>4%; light grey – SVDp<4%). B) Diﬀerences in the MRI parameters between the identiﬁed sub-groups. These have been normalised by
the population average to allow all parameters to be shown on a single plot. C) Diﬀerences in the cognitive parameters between the identiﬁed sub-groups, dashed line
indicates population average. D) Diﬀerences in the rate of change in the cognitive proﬁle, dashed line indicates population average.
Table 3
Baseline demographic, MRI and cognitive parameters for the dementia subgroups deﬁned using cluster ward-linkage.
GROUP 1 GROUP 2 GROUP 3 GROUP 4
Demographics N 5 2 5 10
Correctly predicted (%) 0 0 80 70
Average age (years) 65.02 (10.67) 78.33 (9.90) 75.93 (7.97) 74.91 (7.23)
Male (%) 60 50 60 70
Female (%) 40 50 40 30
Rankin 1.20 (1.30) 0.5 (0.71) 2.4 (1.82) 1.6 (1.43)
MMSE 27.40 (2.97) 24.00 (4.24) 22.80 (4.82) 25.00 (3.13)
NART 100.00 (14.93) 102.50 (33.23) 92.20 (12.36) 88.00 (12.53)
Time to dementia onset (years) 3.87 (1.43) 2.82 (0.45) 2.66 (0.77) 2.83 (1.85)
MRI Parameters Mean grey matter (mm3) 649,603 (84615) 667,153 (18905) 651,225 (73883) 690,978 (84449)
Mean white matter (mm3) 281,955 (79245) 308,675 (34558) 331,980 (37052) 336,972 (52306)
Mean total cerebral volume (mm3) 1,002,964 (132771) 1,022,045 (53432) 1,043,029 (106885) 1,052,777 (127415)
Mean lacunar volume (mm3) 1137.60 (948.89) 5.50 (7.78) 706.20 (707.45) 499.00 (381.69)
Mean white matter hyperintesities volume (mm3) 71,406 (26707) 46,218 (31.82) 59,824 (38959) 24,827 (14590)
SVDp: Percentage ratio of WMH to GM volumes (%) 7.27 (3.04) 4.53 (0.24) 5.27 (3.40) 2.28 (1.16)
Cognitive Executive Function −0.68 (1.04) −1.87 (0.15) −1.06 (1.30) −1.73 (0.53)
Processing Speed −0.43 (0.67) −2.02a −0.80 (1.24) −1.72 (0.58)
Global Functioning −0.28 (0.69) −1.24 (0.24) −0.56 (1.14) −1.31 (0.33)
Working Memory 0.00 (0.78) −0.17 (1.18) 0.27 (1.09) −0.77 (0.75)
Long-term Memory −0.05 (1.10) −0.42 (0.12) −0.25 (1.26) −0.74 (0.69)
a Only one data point available, other subject unable to complete task due to unrelated disability.
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Fig. 4. Longitudinal rate of hippocampal atrophy in anatomical subgroups.
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vascular and Alzheimer's like pathology (Fig. 4; Supplementary Fig. 2).
Finally, we have shown that our prediction of dementia from baseline
MRI data can be improved by accounting for the overall level of vas-
cular damage, here deﬁned as a SVDp more or< 4%, which serves as a
simple surrogate marker to stratify the aforementioned groups (i.e. 19%
of individuals with negative predictions but SVDp>4% will develop
dementia within 5y compared to 6% with SVDp<4%).
4.1. Structural correlates of preclinical vascular dementia
In this work, we found marked volumetric reduction in the left
striatum and to a lesser extent anterior hippocampus. Associated with
this, there were increased white-matter hyperintensities, particularly
within the frontal radiations and left centrum semiovale, which has
been previously observed in histologically conﬁrmed vascular dementia
(De Reuck et al., 2016). We also found an asymmetric distribution of
lacunar damage, with more focal lesions within these areas in those
with preclinical dementia that may account for some of these ob-
servations. In particular, 25% of subjects had focal, overlapping da-
mage within the left centrum semiovale, which contains the superior
longitudinal fasciculus and arcuate fasciculus. Therefore lesions in this
area are more likely to cause disruption to the dominant hemisphere
language networks. In a sub-analysis of the group 1 cluster, who had a
primarily vascular dementia, we found that four out of the ﬁve patients
had lacunes in this particular region. Whilst the numbers are small and
should be interpreted with caution, these results suggest that this area,
which has also been highlighted by others (De Reuck et al., 2016;
Nestor et al., 2017), may be a strategic brain region where focal damage
lowers the threshold to manifest symptoms of dementia via disruption
of connecting networks (Nestor et al., 2017). Similarly, lesions parti-
cularly within the dominant hemisphere striatum and thalamic nuclei
(medio-dorsal, ventro-anterior and pulvinar nuclei) were also more
frequently observed in pre-clinical dementia, which is in line with
previous work examining the role of strategic lacunes in cognitive
Fig. 5. Kaplan-Meier survival plots for dementia onset. A. Total group risk plotted with positive and negative SVM predictions (log-rank P=0.002). B. SVM
predictions stratiﬁed according to vascular burden (Low - SVDp<4%; High – SVDp>4%; log-rank P= .005 between SVM prediction groups but not signiﬁcant
within groups).
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impairment (Benisty et al., 2009; Benjamin et al., 2014) and overt
vascular dementia. Importantly, we found no diﬀerences in the voxel-
wise rates of WMH expansion or cortical atrophy between the groups,
indicating that the location of ischaemic lesions are more important
than the rate of SVD progression in the development of future dementia.
Whilst the asymmetry of the results may at ﬁrst appear unexpected, it is
well known that many commonly used cognitive tests, such as the
MMSE, are biased towards dominant left hemisphere function (Nelson
et al., 1986; Kupke et al., 1993). Dementia is a clinically deﬁned syn-
drome and therefore these results may just reﬂect a diagnostic bias, in
that dominant hemisphere damage is simply easier to detect.
4.2. Subtypes of vascular dementia
One strength of this work is the use of strict inclusion criteria to
generate a more homogenous cohort of symptomatic small vessel dis-
ease, deﬁned as evidence of a lacunar infarct as well as conﬂuent leu-
koaraiosis, but without evidence of large cortical infarcts, or other
cause of white matter disease, together with a prolonged period of
longitudinal follow-up. Rather than selecting patients presenting with
cognitive impairment, which might favour recruitment of those with a
mixed dementia we recruited patients with lacunar stroke regardless of
the presence or absence of any cognitive impairment. At recruitment
few had symptomatic cognitive complaints. Any subsequent clinically
diagnosed dementia that developed within this group would auto-
matically fulﬁll the DSM-V criteria (Gold et al., 1997) for vascular de-
mentia. However, it is well established that at post-mortem in elderly
individuals the underlying pathology is either pure Alzheimer's or
mixed Alzheimer's with cerebrovascular disease (Kalaria, 2016), and
only 5–7% will have a pure vascular dementia phenotype (Jellinger and
Attems, 2010; Thal et al., 2012; Kalaria, 2016). The advent of amyloid
PET imaging using the 11C-PiB ligand has allowed this to be better
characterized in vivo by identifying individuals fulﬁlling the diagnostic
criteria for vascular dementia without any evidence of amyloid pa-
thology (Lee et al., 2011; Kim et al., 2014). These studies have shown
that the cohorts with pure vascular dementia tend to be younger, with a
greater burden of vascular damage as indexed by the number of la-
cunes.
In this work, we have identiﬁed four anatomical subtypes within a
group that, as a minimum, has co-existing cerebrovascular disease to
varying degrees (Fig. 5). The ﬁrst group corresponds well with the
descriptions of PiB negative pure vascular dementia, with a younger age
of onset, extensive vascular damage (both WMH and LI) and brain
atrophy, but with a cognitive proﬁle that matches the more classical
descriptions for a subcortical vascular dementia. This group could not
be predicted using our SVM analysis. One possible explanation is that,
given the pre-existing extensive lacunar damage, this group is at high
risk for future lacunar events that may or may not be within a strategic
location, but are inherently unpredictable. Additionally, the imaging
modality used for this work may not have been suﬃciently sensitive to
detect the more diﬀuse damage that is present even in normal ap-
pearing white matter (Maillard et al., 2011). It may be that techniques
such as Diﬀusion Weighted Imaging (DWI) may prove better at pre-
dicting this vascular subgroup by providing more accurate measures of
these white matter abnormalities (Zeestraten et al., 2016), and already
DWI has been shown to predict cognitive impairment in this patient
group (Lawrence et al., 2014; Ciulli et al., 2016). In contrast, group four
had very low levels of vascular disease, but marked memory impair-
ments on cognitive testing, which would be more in keeping with
Alzheimer's-like pathology (i.e. mixed Alzheimer's with associated
cerebrovascular disease). The relatively predictable anatomical-clinical
progression of this pathology also renders it easier to detect during the
preclinical phase (Csernansky et al., 2005; Tondelli et al., 2012), and
our classiﬁcation parameters are similar to comparable work in pre-
clinical Alzheimer's (Plant et al., 2010; Trzepacz et al., 2014). Fur-
thermore, the observation that subcortical morphometric properties of
the hippocampus, striatum, and to a lesser extent thalamus, provide
much more accurate predictions in this AD-like group, align well with
regional cortico-subcortical network disruptions that have previously
been reported in AD associated with SVD (Nestor et al., 2017). The
remaining two groups lay between these two extremes, with progres-
sively decreasing amounts of vascular disease and increasing memory
impairments.
The ability to reliably separate the two pathological extremes has
several direct applications. First, it provides a quick, cheap, simple
technique to predict and remove the majority of individuals with in-
cipient Alzheimer's like pathology and provide an enriched cohort with
“pure” vascular pathology where 19% will develop dementia within
ﬁve years. It is likely that diﬀerent therapies for Alzheimer's pathology
and pure vascular pathology will be required, and mixing of the two
pathologies may account for the mixed results achieved through pre-
vious clinical trials in vascular dementia (Kavirajan and Schneider,
2007; Skoog et al., 2012; Baskys and Cheng, 2012). Providing a way to
better phenotype the baseline cohort will allow appropriately targeted
clinical therapies, for example acetylcholinesterase inhibitors in the
Alzheimer's cohorts versus aggressive blood pressure management in
the vascular groups. Furthermore due to the simple nature of this
technique, requiring only T1 weighted and FLAIR MRI images, it could
be applied to pre-existing clinical trial datasets to investigate sub-group
eﬀects.
4.3. Limitations
The small group size of the preclinical vascular dementia cohort is a
fundamental limitation to further sub-group analysis. Furthermore,
there is no gold-standard post-mortem diagnosis for any of the patients,
nor is there direct evidence for amyloid pathology in this work. Future
work correlating the MRI results with either histology or PET imaging
would be required to verify these ﬁndings. Based on previous histolo-
gical studies it is extremely likely that the underlying pathology ob-
served in the work is Alzheimer's, as supported by the subgroup rates of
hippocampal atrophy (Fig. 4). However, due to the use of inferred (i.e.
psychometric proﬁles, MRI parameters, rate maps) rather than direct
evidence led us to adopt the term “Alzheimer's like” throughout the
paper. Due to the inclusion criteria used, even those with a more
“Alzheimer's like” pattern would be classiﬁed as mixed pathology (i.e.
mixed Alzheimer's with associated cerebrovascular disease). However,
our results allow this heterogeneous group to be stratiﬁed according to
the likely predominant pathology, consistent with the latest re-
commendations (Custodio et al., 2017).
Post-diagnosis MRI scans were unavailable for the majority of our
cohort, and therefore it is not possible to accurately deﬁne whether
strategic lacunar events contributed to the ﬁnal diagnosis. While di-
agnostic labels from the participant's routine clinical care are unavail-
able, but these are unlikely to have helped validate the proposed
models as the discrepancy between clinical diagnosis by experts and
post mortem can be as high as 20% (Archer et al., 2017), and standard
clinical care would be unlikely to perform annual imaging and psy-
chometric assessments at the same frequency as used in this work.
Whilst we did achieve classiﬁcation parameters that were compar-
able with work in Alzheimer's (Csernansky et al., 2005; Tondelli et al.,
2012), it may be possible to further improve on this by using the ana-
tomical subtypes to reﬁne cohorts into more phenotypically homo-
genous cohorts. However to achieve this, greater numbers would be
required in each group. It may be that using MRI modalities that are
more sensitive to white matter damage, such as diﬀusion weighted
imaging, combined with more advanced classiﬁcation methods that can
combine multimodal data-sources (such as inﬁnite kernel learning
(Gehler and Nowozin, 2008)) would improve the classiﬁcation para-
meters still further. However, achieving this requires substantial
methodological development and is currently the focus of ongoing
work.
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It is acknowledged that our SVM analysis resulted in the best per-
forming model using anatomical regions that are known to be involved
in Alzheimer's disease rather than pure subcortical vascular dementia.
Despite this, the agreement between these SVM results and anatomical
clustering analysis are noteworthy. Despite the two approaches being
independent of one another, they converge on a common solution and
result in clinically coherent phenotypes that also agree with the broader
literature, supporting the interpretation and proposed subgroups.
Finally, whilst the focus of this work was to develop a technique that
required only a single time-point to enable patient stratiﬁcation, it may
be that addition of further time-points may further improve the pre-
clinical diagnosis.
5. Conclusion
Overall this work demonstrates that at a voxel-wise level, the pat-
tern of disease is more important than the rate of progression in de-
termining whether patients with SVD progress to dementia. We de-
monstrate that within a relatively homogenous cohort of cerebral small
vessel disease, separate anatomical endophenotypes can be identiﬁed
that correlate with long term clinical outcome, and that preclinical
dementia in the groups with more Alzheimer's like pathology can be
reliably predicted over three years before onset.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.nicl.2018.06.023.
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